Filter News
Area of Research
- (-) Nuclear Science and Technology (13)
- Advanced Manufacturing (4)
- Biology and Environment (20)
- Building Technologies (1)
- Clean Energy (55)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (12)
- Electricity and Smart Grid (1)
- Fusion and Fission (12)
- Fusion Energy (8)
- Isotope Development and Production (1)
- Isotopes (4)
- Materials (58)
- Materials for Computing (8)
- Mathematics (1)
- National Security (20)
- Neutron Science (26)
- Quantum information Science (4)
- Sensors and Controls (1)
- Supercomputing (63)
News Topics
- (-) Biomedical (2)
- (-) Computer Science (1)
- (-) Fusion (2)
- (-) Molten Salt (3)
- (-) Physics (1)
- (-) Space Exploration (4)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Decarbonization (1)
- Isotopes (3)
- Materials Science (1)
- Neutron Science (3)
- Nuclear Energy (17)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.